Antibiotics and Machine Learning

VENICE, Fla. - July 22, 2021 - PRLog -- The complexity and rise of data in healthcare means that artificial intelligence (AI) will increasingly be applied within the healthcare field. Several types of AI are already being employed by providers of care.

Innovation of deep-learning models will be able to screen millions of chemical compounds within a few hours and will be able to target potential antibiotics that kills bacteria using different mechanisms than of existing drugs. Various models exist, but the perspective of leadership arose from experience conducting an empirical study of organizations created within the National Health Service in England to foster innovation for patient benefit, such as new technologies and models of care.

Companies such as Wyoming Investor (http://wyominginvestor.com) are developing technology and machine learning to make sense of mountains of biomedical data which will prominently increase the success rate of antibiotics to fight gram-positive bacteria that are resistant to other antibiotics while working side-by-side with antibiotic such as Linezolid.